Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLLAnna Vardi, Paolo Ghia, Antonis Dagklis et al.|Blood|2013Cited by 93
Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life AnalysisEleni Gavriilaki, Ioanna Sakellari, Alkistis Panteliadou et al.|Cancers|2023Cited by 19
Endothelial Injury Following CAR-T Cell Immunotherapy for Hematological MalignanciesChristos Demosthenous, Eleni Gavriilaki, Paschalis Evangelidis et al.|Cancers|2025Cited by 13
EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapyEleni Gavriilaki, Ioannis Baltadakis, Ifigeneia Tzannou et al.|Blood Vessels Thrombosis & Hemostasis|2024Cited by 12
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell RecipientsEleni Gavriilaki, Ioannis Papassotiriou, Christos Demosthenous et al.|International Journal of Molecular Sciences|2024Cited by 9